Although age-associated changes in left ventricular diastolic function are well recognized, limited data exist characterizing measures of diastolic function in older adults, including both reference ranges reflecting the older adult population and prognostically relevant values for incident heart failure (HF), as well as their associations with circulating biomarkers of HF risk.
T he prevalence of heart failure (HF) increases exponentially with age, disproportionately burdening the elderly, who are projected to account for 20% of the US population by 2030. [1] [2] [3] HF with preserved left ventricular (LV) ejection fraction, which makes up half of HF cases overall, 4, 5 accounts for up to 80% of prevalent HF in the elderly. 6 LV diastolic dysfunction, occurring in parallel with age and accelerated by common cardiovascular risk factors, is the primary pathophysiological abnormality underlying HF with preserved ejection fraction, although abnormalities of LV systolic deformation have also been implicated. 7 Echocardiographic measures of diastolic dysfunction detected in asymptomatic individuals are significant and robust predictors of incident HF and mortality. [8] [9] [10] Age-related changes in cardiac structure and function are well recognized and have made the clinical determination of abnormal LV diastolic function particularly challenging in the elderly. These age-associated changes include smaller LV size, greater LV ejection fraction, lower tissue Doppler imaging (TDI) relaxation velocities (e'), and greater left atrial (LA) size and, although related to age-associated increases in cardiovascular risk factors, are also observed in older adults free of cardiovascular risk factors. [11] [12] [13] [14] [15] [16] [17] [18] Surprisingly few data exist on normative values of echocardiographic measures of LV diastolic function in older adults, their association with circulating biomarkers of HF risk, and their prognostic relevance for incident HF in older adults. Indeed, existing estimates are based predominantly on data from younger populations, and current guideline recommendations specifically cite the need for more data in the elderly. 19, 20 We studied community-dwelling adults 65 to 90 years old participating in the ARIC study (Atherosclerosis Risk in Communities) who underwent comprehensive echocardiography at the fifth study visit. We determined normative values for diastolic measures in older adults on the basis of their distribution in a subgroup of participants who were free of prevalent cardiovascular disease or major cardiovascular risk factors, including hypertension, diabetes mellitus, obesity, chronic kidney disease, and active smoking. We then assessed the association of these measures with circulating N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and with incident HF or mortality in the overall ARIC sample, and we validated our findings in independent samples.
METHODS

Study Population
ARIC is a prospective, epidemiological, cohort study. Its design and methods have been previously described. 21 Between 1987 and 1989, 15 792 middle-aged subjects were enrolled in 4 communities in the United States: Forsyth County, North Carolina; Jackson, MS; suburban Minneapolis, MN; and Washington County, Maryland. Between 2011 and 2013, 6538 participants returned for a fifth study visit that included standardized comprehensive echocardiography in addition to anthropometrics, interviewer-administered questionnaires, and laboratory testing. The study protocol was approved by institutional review boards at each field center, and all participants provided written informed consent. This analysis included 5801 participants with echocardiographic data at visit 5 who were free of prevalent HF.
To define a subset of low-risk participants free of prevalent cardiovascular disease or risk factors (referred to as the low-risk reference subgroup), we excluded participants with (1) prevalent cardiovascular disease, including coronary heart disease (myocardial infarction history or regional wall motion abnormality on echocardiography), prior HF hospitalization or self-report, atrial fibrillation, and moderate or greater valvular disease; (2) hypertension; (3) diabetes mellitus; (4) visit 5 body mass index of >30 or <18.5 kg/m 2 ; (5) chronic kidney disease defined as an estimated glomerular filtration rate <60 mL·min −1 ·1.73 m −2 at visit 5; (6) QRS duration ≥120 milliseconds at visit 5; or (7) active smoking.
Clinical Perspective
What Is New?
• Age-associated changes in left ventricular diastolic function are well recognized, but limited data exist on normative values in the elderly and their association with incident heart failure.
• We relate diastolic measures (tissue Doppler imaging e', E/e', and left atrial size) to risk of heart failure hospitalization or death in 5801 elderly participants in the Atherosclerosis Risk in Communities study and defined sex-specific 10th percentile limits in 401 participants free of cardiovascular disease or risk factors.
• Each diastolic measure was robustly associated with incident heart failure hospitalization or death.
• Reference limits for E/e' and left atrial size were generally in agreement with existing guidelines, whereas limits for tissue Doppler imaging e' were substantially lower.
What Are the Clinical Implications?
• Compared with guideline cut points, ARIC-based limits improved risk discrimination and reclassified more than one third of the study population as having normal diastolic function.
• With these limits, 46% had normal diastolic measures and were at low risk (1%/y), 49% had 1 or 2 abnormal measures and were at intermediate risk (2.4%/y), and 5% had all 3 abnormal diastolic measures and were at high risk (7.5%/y).
• These findings suggest that a decline in left ventricular longitudinal relaxation velocity occurs as a part of healthy aging and is largely prognostically benign and support the use of age-based normative values in an elderly population.
Prevalent hypertension and diabetes mellitus were based on blood pressure and glucose measured from study visits 1 through 5, self-report, and medication use. ARIC participants undergo surveillance for incident coronary heart disease events (including definite or probable myocardial infarction or coronary revascularization) as previously described in detail. 22 Prevalent HF was based on hospitalization International Classification of Diseases codes before 2005 23 with additional physician adjudication since 2005 as previously described. 24 Atrial fibrillation was ascertained from ECGs at 5 study visits and hospital discharge records as previously described. 25 For incident HF and death after visit 5, incident HF was based on HF hospitalization or HF death according to International Classification of Diseases codes (code 410 in any position) obtained by ARIC surveillance of hospital discharges. 23 Deaths were ascertained by ARIC surveillance or the National Death Index. 22 
Echocardiography
Design and methods of echocardiography in ARIC visit 5 have previously been described in detail. 26 Briefly, studies were acquired in participants attending visit 5 at all 4 field centers by certified study sonographers using uniform imaging equipment and following a standardized image acquisition protocol. Quantitative measures were performed by blinded analysts at a dedicated core laboratory on the basis of the recommendations of the American Society of Echocardiography. 19, 20 Reproducibility metrics were excellent, as previously reported. 26 
Statistical Methods
Echocardiographic measures of LV diastolic function were described in the low-risk reference subgroup overall and stratified by sex. Because empirical estimates of distribution limits can vary substantially in small to moderate-sized samples, we used quantile regression (STATA qreg) to define 10th, 50th, and 90th percentile limits with associated 95% confidence interval (CI) in the low-risk reference subgroup overall and stratified by sex. Self-reported race was not significantly associated with reference limits for any echocardiographic measure in quantile regression equations adjusted for sex and race. The resulting 10th and 90th percentile limits were considered reference limits for these measures in the overall ARIC sample.
Among ARIC participants attending visit 5 and free of prevalent HF, atrial fibrillation at the time of echocardiography, and moderate or greater valvular disease (analysis set n=5356), the cross-sectional continuous association of TDI e', E/e', LA width, and LA volume index (LAVi) with log-transformed NT-proBNP levels was assessed with restricted cubic splines. The number of knots that minimized model Akaike information criterion was selected (3-6 knots assessed). Four knots were used for TDI e', and 3 knots were used for E/e' ratio, LA width, and LAVi. In the overall ARIC sample free of prevalent HF (n=5801), the continuous associations between incidence rates of HF hospitalization or all-cause mortality and TDI e', E/e', LA width, and LAVi were assessed by Poisson regression models. The association of abnormal values, based on either ARIC reference limits or guideline-based cut points, with incident HF hospitalization or all-cause mortality was assessed by multivariable Cox proportional hazard models adjusted for age, sex, and race. For cubic splines of incident rates associated with LV functional measures, 3 knots resulted in the lowest model Akaike information criterion (3-6 knots were assessed).
ARIC-based reference limits were appreciably different from guideline recommendations for TDI e'. We therefore assessed the association of abnormal values of septal and lateral TDI e' based on either ARIC reference limits or guideline-based cut points with incidence of HF hospitalization or death in patients ≥65 years of age in 2 independent samples with prevalent cardiovascular disease: the echocardiographic substudies of the ENGAGE AF-TIMI 48 trial (Effective Anticoagulation With Factor XA Next Generation in AF-Thrombolysis in Myocardial Infarction 48) of patients with atrial fibrillation, 27 and the TOPCAT trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) of patients with HF with preserved ejection fraction. 28 Cox proportional hazard models were adjusted for age, sex, and race in analysis of the TOPCAT echocardiography study and for age and sex in the analysis of the ENGAGE AF-TIMI 48 echocardiography study.
As an additional confirmatory analysis, we attempted to identify thresholds of TDI e' to distinguish normal and abnormal levels in ARIC and in these 2 independent samples on the basis of the ability of a given cut point to identify patients at increased risk of incident HF hospitalization or death (optimal cut point analysis). With the use of a method similar to a 1-step classification and regression tree analysis, 29 a sequence of candidate thresholds was considered: TDI e' septal 1-cm/s increments between 3 and 10 cm/s and TDI e' lateral 1-cm/s increments between 3 and 11 cm/s. The threshold associated with the most significant hazard ratio was selected. All event rates and hazard ratios using ARIC-based limits presented in the tables and figures are based on the 10th percentile distribution limits from the low-risk subgroup of participants free of cardiovascular disease or risk factors.
To assess the potential clinical impact of using reference values for diastolic measures derived from ARIC, we compared the prevalence of abnormal diastolic measures using these thresholds and guideline-based thresholds 20 and their associated event rates. We then determined the reclassification characteristics of these ARIC-based thresholds and their incremental value relative to guideline-based thresholds using the continuous net reclassification improvement and integrated discrimination improvement at 2 years using time-to-event data. 30 We sought to replicate these findings in an independent, elderly, population-based study. Reclassification characteristics and incremental value metrics of classification based on ARIC thresholds relative to guideline cut points were therefore evaluated in participants ≥65 years of age in the echocardiographic substudy of the fourth examination of Copenhagen City Heart Study (2001-2003; n=563) . [31] [32] [33] Because TDI e' was assessed by color TDI in the Copenhagen City Heart Study but by spectral pulsed TDI in ARIC, we converted TDI e' values to those equivalent to spectral pulsed TDI using a validated equation. 34 Continuous net reclassification improvement and integrated discrimination improvement at 8.6 years were calculated with time-to-event data.
A 2-sided value of P<0.05 was considered statistically significant. All analyses were performed with STATA 13 (StataCorp, College Station, TX) and R version 3.2.0.
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RESULTS
Clinical characteristics of the study population are shown in Table 1 . Of the 5801 participants included in this analysis, 401 (7%) were included in the low-risk reference subgroup. The mean age of the low-risk reference subgroup was 74.7±4.6 years; 34% were male; and 7% were black. Compared with the larger population of participants in the risk factor subgroup, the lowrisk reference subgroup was younger, more likely female, and less likely black and had lower median levels of high-sensitivity C-reactive protein, NT-proBNP, and high-sensitivity troponin T. By design, the prevalence of cardiovascular risk factors was lower, as were blood pressure and heart rate, whereas estimated glomerular filtration rate was higher.
The lower reference limits for TDI e' septal and e' lateral , based on our low-risk reference subgroup, were 4.6 and 5.2 cm/s, respectively (Table 2) . Limits for TDI e' septal velocity tended to be similar between the sexes, whereas limits for TDI e' lateral tended to be lower in women compared with men (5.1 and 5.4 cm/s, respectively). Reference limits for E/e' septal and E/e' lateral were 14.4 and 12.7, respectively, and tended to be higher in women compared with men. Reference limits for LA width were 3.7 and 4.0 cm in women and men, respectively, and the upper reference limit for LAVi was 30 mL/m 2 and was similar between sexes. Among the broader ARIC study sample free of prevalent HF, TDI e' (septal or lateral) was abnormally low in 29%, E/e' ratio was abnormally high in 31%, and LAVi was abnormally enlarged in 23% with these reference limits. Only modest differences in the prevalence abnormal measures were noted by sex and race (Tables I and II in the online-only Data Supplement).
All diastolic measures were robustly associated with NT-proBNP levels in cross-sectional analysis (all P<0.0001; Figure 1 ) and with incident HF hospitalization or death (all P≤0.003; Figure 2 ). Although they explained a small proportion of population-level variability of NTproBNP ( Figure I in the online-only Data Supplement), these measures were highly significantly associated with NT-proBNP levels, with ≈2-fold differences in geometric mean NT-proBNP values for patients with lower versus higher measures of diastolic dysfunction (Figure 1 ). Both septal and lateral TDI e' demonstrated nonlinear associations with NT-proBNP ( Figure 1A and 1B) and with incident HF hospitalization and death (Figure 2A and 2B) , with a steeper risk in incidence rates noted for e' septal and e' lateral values below ≈5.4 and 6.4 cm/s, respectively. Although E/e' septal and E/e' lateral were statistically nonlinearly associated with NT-proBNP ( Figure 1C and 1D) , both demonstrated linear association with outcomes such that higher values were associated with higher incidence rates without evidence of a threshold ( Figure 2C and 2D) . Larger LA size was monotonically associated with higher NT-proBNP levels and higher risk of HF hospitalization or death, although this association with outcomes was linear for LA width ( Figure 2E ) and nonlinear for LAVi (Figure 2F) . Sex did not significantly modify the association of diastolic measures with incident HF or death (Table  I in the online-only Data Supplement), whereas the risk associated with abnormal TDI e' and E/e' tended to be higher in black compared with white participants (Table II in the online-only Data Supplement).
One hundred forty-seven events occurred over a median follow-up of 610 days (25th to 75th percentile range, 469-762 days). Abnormal E/e', LA dimension, and LAVi were significantly associated with incident death or HF hospitalization when classified with either ARIC-based reference limits or guideline cut points (Table 3 ). In contrast, abnormal TDI e' septal and e' lateral were significantly associated with incident death or HF only when defined with ARIC-based reference limits and were not associated with these outcomes when defined with guideline-based cut points. Similarly, in 2 independent samples, one with HF with preserved ejection fraction and the other with atrial fibrillation, abnormal TDI e' septal was significantly associated with incident HF hospitalization or death only when defined with ARIC-based reference limits, not when de- or all-cause mortality; ENGAGE-TIMI 48, incident heart failure or all-cause mortality; and TOPCAT, heart failure hospitalization or all-cause mortality. Risk presented as hazard ratio (95% confidence interval) adjusted for age, sex, and race in ARIC and TOPCAT and for age and sex in ENGAGE AF-TIMI 48.
fined with guideline-based cut points (Table 4) . TDI e' lateral was not significantly associated with the composite end point in these other studies. Given the large difference in ARIC-based reference limits for TDI e' compared with guideline recommendations (Figure 3A) , we explored the optimal cut point values for these measures for predicting death or HF hospitalization (optimal cut point analysis in Table 4 ). The cut points for septal and lateral TDI e' more closely approximated the ARIC-based limits than the guideline cut points.
When the reference limits derived from the 10th percentile limits in our low-risk reference subgroup were applied to the larger study sample free of prevalent HF, 46% had normal diastolic measures, 31% had 1 abnormal measure, 18% had 2 abnormal measures, and 5% had 3 abnormal measures ( Figure 3B ). Participants with normal diastolic measures demonstrated the lowest event rates; those with 3 abnormal measures demonstrated the highest event rates; and those with 1 or 2 abnormal measures demonstrated intermediate event rates (Figure 3B ). In contrast, guideline-based cut points classified the majority of participants as having 1 abnormality and only 4% as having normal diastolic function. Compared with classification based on guidelinerecommended cut points, ARIC-based reference limits reclassified 2419 participants (42.4% of the total study sample) from having 1 abnormality to having normal diastolic function (Figure 4 ). These participants reclassified to normal diastolic function experienced incident HF hospitalization or death at a rate similar to those classified as normal by both classifications ( Reclassification metrics of ARIC-based versus guideline cut points were assessed in an independent population-based study sample of 563 participants ≥65 years of age in the Copenhagen City Heart Study, [31] [32] [33] This population has a mean age of 74.2±6.2 years; 65% were women; all were white; and they experienced 274 incident HF hospitalizations or death over a mean follow-up of 8.6±3.3 years. Compared with classification based on guideline cut points, ARIC-based reference limits reclassified 289 (51% of the total study population) from having 1 abnormal diastolic measure to normal diastolic function ( Figure 5 Overall annualized event rates in the Copenhagen City Heart Study were higher than in ARIC because of the significantly longer follow-up period (1.7 years in ARIC versus 8.6 years in the Copenhagen City Heart Study) and significant age-related increase in mortality in this age range (mean age, 75 years at baseline in both studies).
DISCUSSION
This analysis is one of the largest to provide normative data on routinely clinically reported measures of LV diastolic function among older adults; to apply these reference limits to a large, biracial cohort of elderly community-dwelling persons; and to relate these measures to prognostically relevant biomarkers and clinical outcomes. Each measure of LV diastolic function was robustly associated with circulating NT-proBNP levels and incident HF hospitalization or death. Reference limits for E/e' and LA size in the elderly are generally in agreement with existing guideline recommendations, whereas limits for TDI e' are substantially lower than existing guideline recommendations. TDI e' demonstrated a nonlinear association with NT-proBNP and incident HF hospitalization or death, with inflection points for risk supportive Figure 4 . Reclassification across diastolic dysfunction score using ARIC-based reference limits from diastolic dysfunction score categories based on guideline-recommended cut points in the overall ARIC sample. of ARIC-based reference limits. Compared with existing guideline-based cut points, ARIC-based reference limits for diastolic function improved risk discrimination and reclassified more than one third of the study population as having normal diastolic function. These participants demonstrated a low risk of HF hospitalization or death.
Age-related decline in LV longitudinal relaxation velocities, reflective of early diastolic relaxation, is well recognized on the basis of data from cross-sectional studies (Table III in the online-only Data Supplement). Indeed, although ARIC-based reference limits for E/e' and LAVi were similar to guideline cut points, the reference limits for TDI septal and lateral e' from the ARIC low-risk reference group (4.6 and 5.2 cm/s, respectively) were appreciably lower than guideline recommendations (7 and 10 cm/s, respectively). 20 These ARIC-based reference limits classified TDI e' as abnormal in 28% of the overall study sample free of prevalent HF compared with 95% by guideline-based cut points. ARIC-based limits for TDI e' were similar to values from healthy populations of a similar age (Table III in the  online-only Data Supplement) , [35] [36] [37] including individuals >60 years of age in the NORRE study (Normal Reference Ranges for Echocardiography) 38 and 65 to 75 years of age in the LOLIPOP study (London Life Sciences Prospective Population Study). 39 Compared with younger cohorts, these limits derived from our low-risk reference subgroup of participants suggest that decline in LV longitudinal relaxation velocities (TDI e') occurs as a part of healthy aging. Future longitudinal studies with serial echocardiograms over time will be necessary to define the factors influencing decline in longitudinal relaxation velocities with age. It is important to note that 3 of our findings also suggest that much of these age-related changes in TDI e' are prognostically benign as opposed to reflecting malignant cardiac senescence. First, our low-risk reference subgroup of 401 participants, from whom these limits were derived, demonstrated a very low incidence of HF hospitalization or death during the follow-up period (incidence rate, 0.4 [95% CI, 0.1-1.3] per 100 person-years). Second, among the full sample of 5801 ARIC participants free of prevalent HF, the ARIC-based reference limits for TDI e' identified values below which lower e' was associated with a higher incidence of death or HF hospitalization. In contrast, abnormal TDI e' was not robustly associated with incident events at values defined by guideline-based cut points. Similar findings were noted when ARIC-based reference limits were compared with guideline cut points for abnormal TDI e' in elderly patients with HF with preserved ejection fraction in the TOPCAT echocardiographic substudy and elderly patients with atrial fibrillation in the ENGAGE-TIMI 48 echocardiographic substudy. Last, these thresholds for risk were not unique to ARIC, with similar thresholds identified in elderly patients in the TOPCAT and ENGAGE-TIMI 48 echocardiographic substudies. Taken together, these findings argue for the use of age-based normative values in interpreting diastolic measures in the elderly. We propose the use of the sex-specific ARIC-based limits specified in Table 3 in individuals ≥65 years of age. Figure 5 . Reclassification across diastolic dysfunction score using ARIC-based reference limits from diastolic dysfunction score categories based on guideline-recommended cut points in participants ≥65 years of age in the Copenhagen City Heart Study. Compared with existing guideline-based cut points, the application of age-appropriate reference limits allowed reclassification of a large proportion of the population from having 1 to 0 abnormal diastolic measures. This large group of participants with normal diastolic measures by ARIC-based limits had a low event rate, demonstrating that age-appropriate reference limits allow the identification of elderly individuals with normal diastolic function who are at low risk for incident HF. Furthermore, we replicated these findings in an independent, elderly, community-based cohort with longitudinal follow-up. These are among the first prognostic data to support the recently revised diastolic function guidelines whereby <2 abnormal measures are considered normal, 2 abnormal measures are indeterminate, and >2 abnormal measures are consistent with diastolic dysfunction. 20 Furthermore, the application of age-appropriate limits in the elderly helps reframe and refine this classification schema such that those without any abnormality in TDI e', E/e', or LA size are at low risk (1%/y over a mean 1.7-year follow-up), those with >2 abnormal diastolic measures are at high risk (7.5%/y), and those with 1 to 2 abnormal diastolic measures are at intermediate risk (2.4%/y).
Race was not significantly associated with reference limits for any echocardiographic measure in quantile regression analysis, suggesting that these sex-specific ARIC-based reference limits are appropriate for both black and white older adults. The risk of incident HF or death associated with abnormally low e' and high E/e' tended to be greater in blacks compared with whites. These findings may help explain the higher incidence of HF in blacks compared with whites, Hispanics, and Asian Americans. 40, 41 Several limitations of this analysis should be recognized. Given the small number of black participants in the low-risk reference subgroup, we were unable to determine reference limits separately by race. However, we found no association of self-reported race independently of sex with reference limits for any echocardiographic measure in quantile regression equations. Measurement error may exist in our assessment of risk factors, leading to misclassification. However, the use of data collected serially over 5 visits to classify risk factors mitigates this limitation. Alterations in LV diastolic function have been observed in overweight individuals (body mass index, 25-30 kg/m 2 ), 42 who were included in our low-risk reference group and may have influenced our ARIC-based reference limits. However, very similar reference limits were observed when we restricted the low-risk reference sample to the 206 participants with a body mass index of 18 to 25 kg/m 2 (Table IV in the online-only Data Supplement), arguing against an appreciable impact of including overweight participants. Follow-up time after echocardiography at ARIC visit 5 was relatively short and may have limited our power to assess the prognostic performance of various reference limits for diastolic measures. Data on HF diagnosed and managed exclusively in the outpatient setting (ie, with no hospitalization event) were not uniformly available, and consistent with prior studies of HF in this cohort, 23, 43 only incident HF hospitalizations were considered.
CONCLUSIONS
In a large, biracial cohort of community-dwelling older adults free of HF, LV diastolic measures are robustly associated with NT-proBNP and with incident HF hospitalization or death. Compared with guideline cut points, ARIC-based reference limits were appreciably lower for TDI e', which was nonlinearly association with incident outcomes with greater associations at values below the ARIC-based reference limit. With the use of these limits, 46% had normal diastolic measures and were at low risk of HF hospitalization or death (1%/y at 1.7-year follow-up), 49% had 1 or 2 abnormal measures and were at intermediate risk (2.4%/y), and all 3 diastolic measures were abnormal in 5% who were at high risk (7.5%/y). These findings suggest that a decline in LV longitudinal relaxation velocity occurs as part of healthy aging and is largely prognostically benign and support the use of age-based normative values in an elderly population.
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